177 related articles for article (PubMed ID: 30785319)
1. New Insulins, Biosimilars, and Insulin Therapy.
Danne T; Heinemann L; Bolinder J
Diabetes Technol Ther; 2019 Feb; 21(S1):S57-S78. PubMed ID: 30785319
[No Abstract] [Full Text] [Related]
2. New Insulins, Biosimilars, and Insulin Therapy.
Danne T; Heinemann L; Bolinder J
Diabetes Technol Ther; 2018 Feb; 20(S1):S55-S70. PubMed ID: 29437477
[No Abstract] [Full Text] [Related]
3. New Insulins, Biosimilars, and Insulin Therapy.
Danne T; Heinemann L; Bolinder J
Diabetes Technol Ther; 2017 Feb; 19(S1):S42-S58. PubMed ID: 28192016
[No Abstract] [Full Text] [Related]
4. New Insulins, Biosimilars, and Insulin Therapy.
Danne T; Heinemann L; Bolinder J
Diabetes Technol Ther; 2016 Feb; 18 Suppl 1():S43-55. PubMed ID: 26836429
[No Abstract] [Full Text] [Related]
5. New Insulins, Biosimilars, and Insulin Therapy.
Danne T; Heinemann L; Bolinder J
Diabetes Technol Ther; 2020 Feb; 22(S1):S32-S46. PubMed ID: 32069160
[No Abstract] [Full Text] [Related]
6. Role of Devices in Insulin Delivery.
Meneghini LF; McNulty JN
Diabetes Technol Ther; 2017 Feb; 19(2):76-78. PubMed ID: 28118052
[No Abstract] [Full Text] [Related]
7. New Insulins, Biosimilars, and Insulin Therapy.
Danne T; Heinemann L; Bolinder J
Diabetes Technol Ther; 2021 Jun; 23(S2):S46-S68. PubMed ID: 34061629
[No Abstract] [Full Text] [Related]
8. New Insulins, Biosimilars, and Insulin Therapy.
Danne T; Heinemann L; Pieber TR
Diabetes Technol Ther; 2023 Feb; 25(S1):S44-S69. PubMed ID: 36802184
[No Abstract] [Full Text] [Related]
9. Interchangeable Insulins - New Pathways for Safe, Effective, Affordable Diabetes Therapy.
Socal MP; Greene JA
N Engl J Med; 2020 Mar; 382(11):981-983. PubMed ID: 32160658
[No Abstract] [Full Text] [Related]
10. Biosimilar products are not bioidentical.
Garber AJ
J Diabetes; 2015 Mar; 7(2):153-4. PubMed ID: 25395269
[No Abstract] [Full Text] [Related]
11. The Cost-Effectiveness of Intermediate-Acting, Long-Acting, Ultralong-Acting, and Biosimilar Insulins for Type 1 Diabetes Mellitus: A Systematic Review.
Saunders H; Pham B; Loong D; Mishra S; Ashoor HM; Antony J; Darvesh N; Bains SK; Jamieson M; Plett D; Trivedi S; Yu CH; Straus SE; Tricco AC; Isaranuwatchai W
Value Health; 2022 Jul; 25(7):1235-1252. PubMed ID: 35341688
[TBL] [Abstract][Full Text] [Related]
12. Biosimilar Insulin and Costs: What Can We Expect?
Heinemann L
J Diabetes Sci Technol; 2015 Sep; 10(2):457-62. PubMed ID: 26350722
[TBL] [Abstract][Full Text] [Related]
13. The impact of biosimilar insulins on the diabetes landscape.
White J; Wagner A; Patel H
J Manag Care Spec Pharm; 2022 Jan; 28(1):91-98. PubMed ID: 34726499
[TBL] [Abstract][Full Text] [Related]
14. Use of Insulin Pump in Neonates and Toddlers.
Klingensmith GJ
Diabetes Technol Ther; 2015 Dec; 17(12):857-9. PubMed ID: 26618720
[No Abstract] [Full Text] [Related]
15. Insulin pumps improve glucose control in children with type 1 diabetes, study finds.
Mayor S
BMJ; 2015 Nov; 351():h5998. PubMed ID: 26556780
[No Abstract] [Full Text] [Related]
16. Biosimilar insulins are coming: what they are, what you need to know.
Edelman S; Polonsky WH; Parkin CG
Curr Med Res Opin; 2014 Nov; 30(11):2217-22. PubMed ID: 25105307
[TBL] [Abstract][Full Text] [Related]
17. SAR342434 - an insulin biosimilar for the treatment of type II diabetes.
Hu J; Wang M; Zhao Y
Expert Opin Biol Ther; 2018 Nov; 18(11):1107-1112. PubMed ID: 30295083
[TBL] [Abstract][Full Text] [Related]
18. A perspective of sensor-augmented insulin pump therapy in the treatment of type 1 diabetes.
Rayfield EJ
Endocr Pract; 2015 Jan; 21(1):91-2. PubMed ID: 25297673
[No Abstract] [Full Text] [Related]
19. Introduction of biosimilar insulins in Europe.
Davies M; Dahl D; Heise T; Kiljanski J; Mathieu C
Diabet Med; 2017 Oct; 34(10):1340-1353. PubMed ID: 28608570
[TBL] [Abstract][Full Text] [Related]
20. Biosimilar insulins: guidance for data interpretation by clinicians and users.
Heinemann L; Home PD; Hompesch M
Diabetes Obes Metab; 2015 Oct; 17(10):911-8. PubMed ID: 25974131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
